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Background: There are no Indian studies correlating the CT pulmonary embolism index
(Qanadli)with right ventricular function andoutcome. In the present studywe aimed to study
the clinical manifestations of patients presenting with acute pulmonary thromboembolism
and correlate the radiographic features with echocardiographic features and outcome.
Methods: Thirty five patients presenting with symptomatic acute pulmonary thromboem-
bolism in between 2011 and 2013 were studied for clinical, radiological and echocardio-
graphic features and outcome (in-hospital & 1 month follow up).
Results: Themean duration of presentation after onset of symptomswas 5.7 ± 3.7 days. Right
ventricular dysfunction was observed in 11 (31.4%) patients. Out of 35 patients in whom CT
pulmonary angiogram performed, 14 patients had Qanadli PE index >60% of whom 11
(78.6%) patients had right ventricular dysfunction. None had right ventricular dysfunction
when PE index was <60% (p < 0.001). There was significant correlation between pulmonary
vascular obstruction index and right ventricular dysfunction (p < 0.0001). Nine (25.7%) pa-
tients were thrombolysed with Streptokinase. Total mortality including in-hospital and 1
month follow up was 11.4% (4 patients). The mortality in patients with PE index >60% was
21.4% and was nil with <60% (p ¼ 0.02). The mortality in patients with right ventricular
dysfunction was 27.2% and was nil without right ventricular dysfunction (p ¼ 0.0075).
Conclusion: A PE index which was shown to be a strong independent predictor of right
ventricular dysfunction in PE, correlating linearly with different variables associated with
higher morbidity and mortality, enabling accurate risk stratification and selection of pa-
tients for more aggressive treatment.
Copyright © 2014, Cardiological Society of India. All rights reserved.0; fax: þ91 877 2288133.
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Pulmonary embolism (PE) is a common problem, yet it is often
difficult to diagnose. No diagnostic test for PTE has utility
unless it is considered in the differential diagnosis. Therefore,
clinicians must remain vigilant to detect PE. Pulmonary em-
bolism ranges from asymptomatic, incidentally discovered
emboli to massive embolism causing immediate death.
The occurrence of Venous thrombosis (VT) is a result of
interplay between environmental and genetic risk factors.1
Important environmental risk factors are advancing age,
male sex and obesity, precipitated by surgery, trauma, cancer,
immobilization (surgical or medical causes), pregnancy and
use of exogenous hormones.2,3 Genetic risk factors increase
the risk of VT during risk periods and of idiopathic VT i.e. VT
occurring in the absence of environmental triggers.4,5
If pulmonary embolism is suspected, a careful assessment
of the patient's history, physical examination, and known risk
factors need to be done. Electrocardiographic (ECG) abnor-
malities like unexplained tachycardia and manifestations of
acute cor pulmonale, such as an S1, Q3, T3 pattern, right
bundle branch block, P-wave pulmonale, or right axis devia-
tion, are more common with massive embolism than with
smaller emboli, but these findings are also nonspecific.6
The chest radiograph is usually nondiagnostic, but it may
help in making an alternative diagnosis. An unexplained
change in arterial oxygen saturation should raise suspicion
because patients with acute pulmonary embolism are usually
manifested with hypoxemia.6
Many modalities of imaging studies have been used in the
diagnosis of acute pulmonary embolism, including ven-
tilationeperfusion scanning, contrast-enhanced computed
tomographic (CT) arteriography, magnetic resonance imaging
(MRI), and standard pulmonary arteriography. Ultrasonogra-
phy, CT venography, MRI, and standard venography imaging
are used for detecting deep venous thrombosis as a surrogate
for acute pulmonary embolism.
The multidetector CT arteriography with very thin sec-
tions, and low scanning times, has the highest sensitivity and
specificity for detecting emboli in the main, lobar, or
segmental pulmonary arteries.7
Risk stratification in acute PE may allow some aggressive
therapeutic approaches to be undertaken so that we can
reduce mortality from ~30% to <10%. Computed Tomographic
pulmonary angiography findings are usually reported either
positive or negative even in present era with little or no
quantitative description about the amount of thrombus pre-
sent. The prognosis of a patient with a single isolated sub-
segmental embolus varies widely when compared to a patient
with a saddle embolus. The clot burden expressed in the form
of an index may have important prognostic and therapeutic
implications and may even provide a reproducible standard
for measuring response to management.8
Various clot burden scores have been described. Among
them Qanadli PE index is simple and easily calculated, which
was derived from the amount and location of the thrombus on
CT images on the basis of a study.8 The index is defined as the
product ofND, whereN is the value of the proximal clot site,
equal to the number of segmental branches arising distally,and D is the degree of obstruction, defined as 1 for partial
obstruction and 2 for total obstruction.
The presence of embolus in a segmental artery was scored
1 point. This value was multiplied by a factor D, defined as 1
for a partially occlusive embolus and 2 for a completely
occlusive embolus. Thus, a totally occlusive thrombus in a
segmental artery was assigned a value of 2. A clot in a prox-
imal artery that gives rise to segmental arteries was scored as
though each segmental artery had an embolus with the same
degree of obstruction as the proximal embolus. Sub-
segmental emboli were scored as a partial obstruction of the
segmental artery. Accordingly, the maximum obstruction
score for each patient was 40 (20 for each lung), and this score
was converted into a percentage.
Echocardiography can aid in deciding the management
strategy by providing findings that strongly suggest hemody-
namically significant pulmonary embolism.9 In patients
without pre-existing cardiopulmonary disease, for the rise in
pulmonary pressures there must be occlusion of at least
25e30% of the pulmonary vasculature and 50e75% before RV
failure ensues.6 Even patients who may initially appear clini-
cally stable, can develop hypotension and shock rapidly once
the RV begins to fail due to high afterload. The physiologic
reaction to the vasoreactive substances released in response
to the event and the cardiopulmonary status of the patient at
baseline can determine the hemodynamic response to an
acute PE episode.6
The right ventricular dysfunction is defined as presence of
right ventricular hypokinesis, interpreted by a qualitative
evaluation of the right ventricular wall motion.10 Acute right
ventricular dysfunction can be considered when 1 or more of
the following findings present: right ventricular dilation (end-
diastolic diameter >30 mm or right ventriculareleft ventricu-
lar end-diastolic diameter ratio >1 in 4-chamber view); or
paradoxical septal systolic movements or pulmonary hyper-
tension (defined as Doppler pulmonary acceleration time
<90 ms or presence of a right ventricular-atrial gradient
>30 mm Hg). In addition, absence of right ventricular wall
hypertrophy (free wall thickness, >7 mm) is needed.11
The prognosis of PE correlates directly with the degree of
hemodynamic compromise and symptomatic or asymptom-
atic RV dysfunction. Cardiogenic shock usually occurs in less
than 5% of patients with PE. The mortality of patients with
cardiogenic shock ranges from 25 to 40%, and is as high as
65e95% in patients requiring mechanical ventilation and
cardiopulmonary resuscitation.12 The patients with massive
PEs (defined as >60% occlusion of the pulmonary vasculature)
who do not have clinical cardiogenic shock, have a much
lower mortality than those patients with shock.12 Although
massive PEs account for nearly 50% of the mortality in pul-
monary embolism the remaining fatalities occur in patients
with submassive or recurrent pulmonary emboli due to
presence of other comorbidities like malignancy or other
cardiopulmonary diseases.
There are few studies done in India evaluating the use-
fulness of the Qanadli PE index in assessing impact of clot
burden on hemodynamic status, right ventricular function,
survival rates and management of patients presenting with
acute PE. Hence we attempted to study the clinical utility of
the index.
Table 1 e Baseline clinical characteristics.
Present study (n ¼ 35) Number (%)
Dyspnea 33 (94.3)
Cough 16 (45.7)
Chest pain 11 (31.4)
Hemoptysis 02 (5.7)
Leg swelling 13 (37.1)
Palpitations 09 (25.7)
Tachypnea (>20 & min) 22 (62.8)
Rales (crackles) 09 (25.7)
Tachycardia (>100/min) 24 (68.6)
Increased pulmonary component of second sound 11 (31.4)
Deep venous thrombosis 09 (25.7)
Diaphoresis 09 (25.7)
Temperature >38.5 C 02 (5.7)
Systolic blood pressure <90 mmHg 09 (25.7)
Homan's sign 04 (11.4)
Right ventricular lift 03 (8.6)
Pleural friction rub 03 (8.6)
Third heart sound 05 (14.3)
Cyanosis 01 (2.8)
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A total of 52 patients with clinical suspicion of acute pulmo-
nary thromboembolism who presented to the Sri Ven-
kateswara Institute ofMedical Sciences (SVIMS), Tirupati from
January 2011 to December 2012 were screened in this pro-
spective study. Among them 35 patients in whom the diag-
nosis of pulmonary embolism was confirmed by CT




and chest roentgenogramwere taken for all patients.
All patients were subjected to CT pulmonary angiography
with intravenous contrast by 128 slice SEIMENS SOMATOM
Definition ASþ computed tomographic machine. CT pulmo-
nary obstruction index calculated by number of segmental or
branch pulmonary arteries involved and expressed in per-
centage of obstruction.
Echocardiogram was performed using PHILIPS IE33 echo-
cardiography machine (Netherlands). In all patients right
atrial and right and left ventricular sizes were measured.
Estimation of tricuspid regurgitation jet velocity measured in
apical four chamber view by continuous wave Doppler. Right
ventricular function was assessed using TAPSE (tricuspid
annular plane systolic excursion).
Patients eligible for thrombolysis were treated with strep-
tokinase. All patients were treated with intravenous unfrac-
tionated heparin/low molecular weight heparin, and oral
anticoagulation was started simultaneously. Supportive
management was given as needed i.e. ionotropes and me-
chanical ventilation.
The outcome of in-hospital stay was analyzed in terms of
occurrence of death, and need for assisted mechanical venti-
lation by KaplaneMeier survival curve. The Receiver operating
curve was used for the cut-off value of PE index. The associ-
ation between categorical variables and the outcome was
evaluated by c2 test and Fisher's exact test. All statistical
analysis was carried out by Statistical Package for Social Sci-
ences (SPSS) software, version 20.0, SPSS Inc., Chicago, USA.3. Results
The mean age of the patients was 47.1 (±12.4) years and
ranged from 25 years to 75 years. Among the patients 20 were
males and 15 were females. The Mean duration of presenta-
tion after onset of symptoms was 5.7 days (±SD 3.7 days). The
baseline clinical characteristics are given in Table 1.
The majority of patients with PE, 34 of 35 (97.1%), were in
sinus rhythmwhile atrial fibrillation occurred in 1 of 35 (2.8%).
S1Q3T3 patternwas present in 18 patients (51.4%). Nonspecific
abnormalities of the ST segment or T-wave were the most
common ECG abnormalities and one or both occurred in 15 of
35 (42.8%) patients with PE. P pulmonale, right ventricular
hypertrophy, right axis deviation, and right bundle branch
block occurred in 6% of patients with PE.
Echocardiogram showed dilated right atrium in 25 patients
(71.4%) and both right atrial and right ventricular dilatation(RV/LV > 1) in 20 patients (57.4%). Pulmonary artery hyper-
tension of moderate to severe degree was evident in 20 pa-
tients (57.4%). Right ventricular dysfunction observed in 11
patients (31.4%). Presence of thrombus in pulmonary artery,
right atrium and right ventricle was evident in 6 (17.1%),
3 (8.6%) and 2 patients (5.7%) respectively.
Preexisting cardiac abnormalities were seen in few pa-
tients. Severe left ventricular dysfunction was present in one
patient. One patient had preexisting rheumatic heart disease
in the form of moderate mitral stenosis. The echocardiogram
was normal in 2 patients (5.7%).
CT pulmonary angiography showed thrombus in main or
branch PA in 21 (60.0%) patients. Among these 14 (40.0%) had
massive burden of thrombus. Remaining 14 (40.0%) patients
had thrombus in segmental branches. The clot burden was
quantitated by Qanadli PE index. The PE index was >60% in 14
patients and <60% in 21 patients. The mean PE index was
51.8% (±17.3).
Out of 35 patients, 14 had PE index >60%. Among the pa-
tients with PE index >60%, 11 patients had right ventricular
dysfunction. None had right ventricular dysfunction when PE
index was <60% (p < 0.001) (Figs. 1 and 4).
Mean duration of hospital stay was 7.5 days (range 5e13
days). Total 9 patients (25.7%) were thrombolysed. Among
these 4 patients (11.4%) required mechanical ventilation. Two
patients recovered with mechanical ventilator support and
other 2 patients couldn't.
Total mortality including in-hospital and 1 month follow
upwas 11.4% (4 patients). Among these, 3 patients who had PE
index >60% and right ventricular dysfunction died in hospital
during the initial admission. Two patients who died during
the initial admission had pre-existing congestive heart failure
due to cardiomyopathy, and the third patient had lung ma-
lignancy. One patient who had ovarian malignancy died after
one month due to bleeding complication.
The mortality in patients with PE index >60% was 21.4%
(p < 0.05) (Fig. 5) The mortality in patients with right ventric-
ular dysfunction was 27.2% (p < 0.05) (Fig. 6) Regression
Fig. 1 e ROC curve for RV dysfunction and Qanadli PE index.
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as independent predictor of mortality (Table 2, Fig. 7).4. Discussion
The present study was aimed at studying the clinical profile,
radiographic features and outcome in patients with acute PE
in India.
The clinical examination of the patients in the present
study showed tachypnea and tachycardia as most common
clinical signs. Hypotension and tachycardia as signs of
cardiogenic shock were present in one fourth of patients
which helped in the management of the patients, because
both signs correlated well with the severity of pulmonary
vascular obstruction in CT angiography (Figs. 2 and 3).Fig. 2 e Correlation between heart rate and PE index.
Fig. 3 e Correlation between systolic blood pressure and PE
index.
Fig. 4 e Chi-square test for PE index vs RV dysfunction.
Fig. 5 e Chi-square test for PE index vs mortality.
Fig. 6 e Chi-square test for RV dysfunction vs mortality.
Fig. 7 e KaplaneMeier survival curve for PE index.
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 6 2 9e6 3 4 633There are several electrocardiographic (ECG) abnormalities
associated with PE, but none are highly specific or sensitive. In
patients with RV failure, the ECGmay show sinus tachycardia,
signs of RV strain, repolarization abnormalities, or ischemia
including a complete or incomplete right bundle branch block,
a right ward axis (>90), an S1Q3T3 pattern, a Qr in lead V1, ST
elevation in V1, or precordial T-wave inversions. The most
frequent abnormalities were sinus tachycardia and nonspe-
cific changes of the ST segment or T-wave. Abnormalities of
the ST segment or T-wave previously have been reported in
more than 40% of patients with PE who had no pre-existing
cardiac or pulmonary disease.6,13 In the present study it was
42.8% of patients.While the electrocardiogram cannot be usedTable 2 e Regression analysis showed PEI is an
independent predictor of mortality.
Independent
variables
Coefficient Std. error T p-value
(Constant) 0.08305
Age 0.0003351 0.003652 0.0918 0.9276
Sex 0.07455 0.08805 0.847 0.4049
Cardiac 0.2630 0.1673 1.572 0.1281
Cancer 1.0788 0.1871 5.765 <0.0001
RVD 0.3247 0.1416 2.294 0.0301
PE index 0.32987 0.13702 2.307 0.0312as a diagnostic tool for PE, it may suggest the presence of
underlying RV dysfunction and/or reveal important alterna-
tive diagnoses (such as myocardial infarction) in patients
presenting with hypotension.
In patients with acute PE, the presence of RV dysfunction
affords an increased mortality. In the present study the right
ventricular dysfunction showed a significant correlation to
mortality (p < 0.05) (Fig. 6). Six studies, including a total of 1773
patients, showed that patients with right ventricular dysfunc-
tionhadat least a 2-foldhigher risk ofdying in theshort term,as
compared with patients without right ventricular dysfunc-
tion.14 The absolute difference ranged from 4% to 18%.13 This
increase is supported by the multivariate analysis in the study
by Ribeiro et al, which showed a relative risk of 6.0.15 In a pro-
spective study by Grifoni Solivotto et al of 209 patients with
documented PE, TTE was found to have a 100% negative pre-
dictive value for predicting PE related death on the basis of RV
dysfunction,butapositivepredictivevaluewasonly5%.11Thus,
transthoracic echo is useful for early detection of RV dysfunc-
tion in normotensive patients who are at higher risk for he-
modynamic decompensation, but with a low specificity (61%).
A pulmonary vascular obstruction of >30% has been shown
to correlate with the presence of RV dysfunction on echo.13
The present study also showed good correlation between
pulmonary vascular obstruction index and right ventricular
dysfunction (p < 0.0001) (Fig. 4).
CT pulmonary angiography (CTPA) has dramatically
improved the quality of imaging of the pulmonary vasculature
in the last decade and has changed the diagnostic approach to
suspected acute pulmonary embolism. The average sensi-
tivity and specificity for detecting pulmonary embolism has
been shown to be 88% and 92e96%, respectively.16 However,
the interpretation of CTPA is mainly focused on the presence
or absence of emboli and a rough estimation of their severity
(massive, extensive, or isolated). A few published articles
confront the challenge of quantifying pulmonary arterial tree
obstruction by developing an obstruction index. In our study,
the obstruction index proposed by Qanadli et al8 was used
because of the simplicity of applying it in routine clinical
practice.
The mean value of the pulmonary artery obstruction index
in the present studywas 51.8% (±17.3) which is higher than that
described by other investigators (Metafratzi ZM et.al17
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 6 2 9e6 3 463439% ± 27%, Qanadli et al8 29% ± 17%). A significant correlation
also exists between the index of Qanadli et al and right
ventricle dilatation. ROC curve analysis (Fig. 1) determined a
cut-off value for Qanadli PEI8 of 60% for the presence of signs of
RVD which is more than that obtained by Qanadli et al8 (40%),
and similar to that of Wu et al18 (60%). A CT obstruction of 60%
or greater will identify more than 90% of patients with right
ventricular dilatation. The present study shows 78% of patients
with right ventricular dysfunction had an index of >60%.
The PE index may have important prognostic value, since
patients with a pulmonary vascular obstruction of more than
60% tended to have a poor clinical outcome (Table 2). In the
study by Wu AS et.al, 83% of the patients with a PE index of
higher than 60% died, while 52 of 53 (98%) patients with an
index of less than 60% lived.18 In our study only 21.4% of pa-
tients died with PE index more than 60% (Fig. 5). But 19 of 20
(95%) patients with PE index less than 60% survived (Fig. 7).
This finding, if valid, would allow the stratification of a pa-
tient's risk of death and might help identify patients who
would benefit from more aggressive treatment strategies,
such as thrombolysis.
Management of patients with acute PE is dictated by the
presence or absence of hemodynamic compromise. Patients
presenting with PE in cardiogenic shock should immediately
receive vasopressor support, anticoagulation, and then be
considered for thrombolysis and/or embolectomy where
available. In our study all 9 patients (26%) with hemodynamic
instability were thrombolysed.
Meta-analyses of lytic therapy trials have shown that the
majority of benefit from thrombolytic therapy is limited to PE
patients with hemodynamic instability. While normotensive
patients with evidence of RV dysfunction and PE index >60%
have increased mortality and thrombolytic therapy has been
shown to improve RV dysfunction, definitive data demon-
strating a significant morbidity and/or mortality benefit from
lytic therapy in this population is lacking. Regression analysis
and KaplaneMeier survival analysis showed that PE index as
an independent predictor of mortality (Table 2, Fig. 7). Further
studies are needed to determine which hemodynamically
stable patients will benefit from lytic therapy in the setting of
RV dysfunction and high PE index.
Death strongly associated with cancer, age, and cardio-
vascular disease.19 In our study 4 patients died of which 2
patients hadmalignancy and other 2 had prior left ventricular
dysfunction.
The main limitation of the study was a small sample size,
so the statistical significance of PE index, right ventricular
dysfunction and mortality may not be comparable to the
larger studies.
In conclusion early diagnosis and risk stratification will
reduce themortality.APE indexwhichwasshowntobeastrong
independent predictor of right ventricular dysfunction in PE,
correlating linearly with different variables associated with
higher morbidity and mortality, enabling accurate risk stratifi-
cation and selection of patients for more aggressive treatment.Conflicts of interest
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